Targeted delivery of interleukin‐12 plasmid into HepG2 cells through folic acid conjugated graphene oxide nanocarrier
Biotechnology Progress · 2024
DOI: 10.1002/btpr.3473 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Progress, 2024. Verfasst von Farshad Safari und 10 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Yasuj University of Medical Sciences, Yasuj, Iran. Hauptthemen laut MEDLINE: Graphite, Folic Acid, Plasmids, Interleukin-12. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Yasuj University of Medical Sciences.
Abstract (Originalsprache)
Successful gene therapy relies on carriers to transfer genetic materials with high efficiency and low toxicity in a targeted manner. To enhance targeted cell binding and uptake, we developed and synthesized a new gene delivery vector based on graphene oxide (GO) modified by branched polyethyleneimine (BPEI) and folic acid (FA). The GO‐PEI‐FA nanocarriers exhibit lower toxicity compared to unmodified PEI, as well as having the potential to efficiently condense and protect pDNA. Interestingly, increasing the polymer content in the polyplex formulation improved plasmid transfer ability. Substituting graphene oxide for PEI at an N/P ratio of 10 in the HepG2 and THP1 cell lines improved hIL‐12 expression by up to approximately eightfold compared to simple PEI, which is twice as high as GO‐PEI‐FA in Hek293 at the same N/P ratio. Therefore, the GO‐PEI‐FA described in this study may serve as a targeting nanocarrier for the delivery of the hIL‐12 plasmid into cells overexpressing folic acid receptors, such as those found in hepatocellular carcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Student Research Committee, Yasuj University of Medical Sciences, Yasuj, Iran.
- Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.
- Pharmaceutical Sciences Research Center, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
- Pharmaceutical and Food Control Department, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
- Medicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.
- Department of Chemistry, Cape Breton University, Sydney, Nova Scotia, Canada.
ORCID-Profile: Farshad Safari, Hassan Bardania, Ali Dehshahri, Somayeh Hallaj-Nezhadi, Arash Asfaram, Vahid Mohammadi, Marzieh Baneshi, Sima Bahramianpour, Negar Akrami, Bahman Khalvati, Ali Mirzaei
Förderung
- Yasuj University of Medical Sciences
Zitieren
APA
Safari, F., Bardania, H., Dehshahri, A., Hallaj-Nezhadi, S., Asfaram, A., Mohammadi, V., Baneshi, M., Bahramianpour, S., Akrami, N., Khalvati, B., & Mirzaei, A. (2024). Targeted delivery of interleukin‐12 plasmid into HepG2 cells through folic acid conjugated graphene oxide nanocarrier. Biotechnology Progress. https://doi.org/10.1002/btpr.3473
Vancouver
Safari F, Bardania H, Dehshahri A, Hallaj-Nezhadi S, Asfaram A, Mohammadi V, et al. Targeted delivery of interleukin‐12 plasmid into HepG2 cells through folic acid conjugated graphene oxide nanocarrier. Biotechnology Progress. 2024. doi:10.1002/btpr.3473
BibTeX
@article{Safari2024,
author = {Safari, Farshad and Bardania, Hassan and Dehshahri, Ali and Hallaj-Nezhadi, Somayeh and Asfaram, Arash and Mohammadi, Vahid and Baneshi, Marzieh and Bahramianpour, Sima and Akrami, Negar and Khalvati, Bahman and Mirzaei, Ali},
title = {Targeted delivery of interleukin‐12 plasmid into HepG2 cells through folic acid conjugated graphene oxide nanocarrier},
journal = {Biotechnology Progress},
year = {2024},
doi = {10.1002/btpr.3473}
}
EUVIMED